Citius PharmaceuticalsCTXR
13F holders, Q4 2024 (December 31)30holders
3famous investors
$4.00avg. 13F price*
At the end of Q4 2024, 30 institutions reported holding Citius Pharmaceuticals Inc. (CTXR) in their 13F filings. The largest holders were Vanguard Group Inc. ($1.0M), Geode Capital Management, LLC ($306K) and BlackRock, Inc. ($289K). 3 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio), Ken Fisher (0.0% of Fisher Asset Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Citius Pharmaceuticals Inc.
- CUSIP
- 17322U306
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $96K |
| Exits | 1 | $83K |
Ownership 30 holders
| Vanguard Group Inc. | 0.00% | No change | 257,631 | $1.0M |
| Geode Capital Management, LLC | 0.00% | Add +1.8% | 76,506 | $306K |
| BlackRock, Inc. | 0.00% | No change | 72,227 | $289K |
| Squarepoint Ops LLC | 0.00% | Add +88.3% | 49,668 | $199K |
| Millennium Management | 0.00% | Reduce -30.3% | 32,320 | $129K |
| UBS Group AG | 0.00% | Add +113813.2% | 27,567 | $110K |
| State Street Corp. | 0.00% | No change | 23,271 | $93K |
| Fisher Asset Management | 0.00% | New | 12,800 | $51K |
| Northern Trust Corp. | 0.00% | No change | 12,773 | $51K |
| Arkadios Wealth Advisors | 0.00% | Add +25.0% | 10,000 | $40K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +4976.7% | 8,212 | $33K |
| IFP Advisors, Inc | 0.00% | New | 7,083 | $28K |
| Group One Trading LLC | 0.00% | Add +483.2% | 4,817 | $19K |
| Royal Bank of Canada | 0.00% | New | 4,000 | $16K |
| SBI Securities Co., Ltd. | 0.00% | — | 2,282 | $9K |
| Osaic Holdings, Inc. | 0.00% | Reduce -95.9% | 1,527 | $6K |
| Simplex Trading, LLC | 0.00% | Add +403.3% | 1,720 | $6K |
| Fairscale Capital, LLC | 0.00% | No change | 366 | $1K |
| Luminist Capital LLC | 0.00% | — | 340 | $1K |
| Morgan Stanley | 0.00% | Add +430.0% | 318 | $1K |
| Murphy & Mullick Capital Management Corp | 0.00% | — | 160 | $640 |
| Princeton Global Asset Management LLC | 0.00% | No change | 160 | $640 |
| JPMorgan Chase & Co. | 0.00% | Add +1.9% | 124 | $496 |
| BNP Paribas Financial Markets | 0.00% | Add +1.4% | 121 | $484 |
| Quent Capital, LLC | 0.00% | Reduce -1.9% | 108 | $432 |
| Citigroup Inc. | 0.00% | Reduce -88.5% | 73 | $292 |
| Bank of America Corp. | 0.00% | Reduce -95.3% | 55 | $220 |
| WR Wealth Planners, LLC | 0.00% | No change | 4 | $16 |
| Danske Bank A/S | 0.00% | New | 2 | $8 |
| Citadel Advisors | 0.00% | New | 1 | $4 |
"% of holder's portfolio" is CTXR's weight in each manager's 13F, not the share of Citius Pharmaceuticals Inc. the manager owns.